No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
XGN250117P7500
- 0.00
- 0.000.00%
15min DelayClose Jan 3 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV-109.50%PremiumJan 17, 2025Expiry Date3.92Intrinsic Value100Multiplier13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Exagen Is Maintained at Buy by Canaccord Genuity
Exagen Price Target Raised to $7.00/Share From $5.00 by Canaccord Genuity
Exagen Analyst Ratings
CCORF Maintains Exagen(XGN.US) With Buy Rating, Raises Target Price to $7
Improved Revenues Required Before Exagen Inc. (NASDAQ:XGN) Stock's 27% Jump Looks Justified
Exagen Reaches 1M Patient Tested Vy AVISE CTD Milestone